Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for Q9H4L7

Entry ID Method Resolution Chain Position Source
6H3A X-ray 550 A B/D 95-347 PDB
6QU1 X-ray 370 A D 151-198 PDB
7Z36 X-ray 280 A C/S 148-198 PDB
AF-Q9H4L7-F1 Predicted AlphaFoldDB

544 variants for Q9H4L7

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV001291509
rs1753894795
853 S>T Neurodevelopmental disorder [ClinVar] Yes ClinVar
dbSNP
CA357674605
rs1229517841
2 N>S No ClinGen
gnomAD
TCGA novel 3 L>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357674611
rs1220383889
3 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1330794490
CA357674616
4 F>L No ClinGen
gnomAD
CA3012956
rs200143335
5 N>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs201340263
CA357674629
5 N>K No ClinGen
1000Genomes
ExAC
gnomAD
rs1281392142
CA357674626
5 N>S No ClinGen
TOPMed
rs1487431135
CA357674640
7 D>V No ClinGen
gnomAD
rs1351299800
CA357674645
8 R>C No ClinGen
TOPMed
rs752567514
COSM277381
CA3012959
10 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1180157935
CA357674659
10 R>H No ClinGen
gnomAD
rs777413974
CA3012961
12 E>D No ClinGen
ExAC
gnomAD
rs746504711
CA3012962
13 K>E No ClinGen
ExAC
TOPMed
gnomAD
CA357674696
rs1417508792
15 N>K No ClinGen
gnomAD
CA3012963
rs770492286
15 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA3012964
rs780582888
16 K>R No ClinGen
ExAC
TOPMed
gnomAD
COSM1730705
CA357674701
rs780582888
16 K>T liver [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA357674711
rs1359351804
17 I>M No ClinGen
TOPMed
gnomAD
rs955261522
CA101658727
19 E>A No ClinGen
Ensembl
CA357674720
rs1449674508
19 E>K No ClinGen
TOPMed
gnomAD
CA3012965
rs749813218
20 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs895263423
CA101658731
23 A>S No ClinGen
TOPMed
CA101658738
rs946694105
23 A>V No ClinGen
TOPMed
CA101658745
rs774542369
24 T>A No ClinGen
ExAC
TOPMed
CA3012967
rs774542369
24 T>S No ClinGen
ExAC
TOPMed
rs1560504546
CA357674756
25 P>A No ClinGen
Ensembl
CA357674759
rs1311954357
25 P>L No ClinGen
TOPMed
gnomAD
CA357674768
rs748529019
27 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA357674772
rs1223552257
27 P>L No ClinGen
TOPMed
gnomAD
rs748529019
CA3012968
27 P>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 27 P>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772364440
CA101658768
28 S>C No ClinGen
ExAC
gnomAD
rs772364440
CA3012969
28 S>F No ClinGen
ExAC
gnomAD
rs760805792
CA3012971
29 Q>H No ClinGen
ExAC
gnomAD
CA3012972
rs766417188
30 P>L No ClinGen
ExAC
CA101658800
rs908180052
32 P>R No ClinGen
Ensembl
TCGA novel 34 S>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357674811
rs1269163525
34 S>L No ClinGen
gnomAD
CA101658827
rs999746719
35 P>S No ClinGen
TOPMed
rs1429264424
CA357674829
37 S>F No ClinGen
Ensembl
CA3012975
rs374058320
38 L>V No ClinGen
ESP
ExAC
gnomAD
rs961050401
CA101658858
39 S>I No ClinGen
TOPMed
gnomAD
rs961050401
CA357674839
39 S>T No ClinGen
TOPMed
gnomAD
CA357674850
rs1437639754
41 E>A No ClinGen
gnomAD
CA3012976
rs752372963
41 E>Q No ClinGen
ExAC
CA357674852
rs1437639754
41 E>V No ClinGen
gnomAD
CA357674861
rs1560504655
42 E>D No ClinGen
Ensembl
CA357674855
rs1261850925
42 E>K No ClinGen
TOPMed
CA3012977
rs758244473
43 E>K No ClinGen
ExAC
gnomAD
CA357674871
rs1425505009
44 N>D No ClinGen
gnomAD
rs11541129
CA101658913
50 S>N No ClinGen
Ensembl
rs1560504694
CA357674919
51 R>G No ClinGen
Ensembl
CA3012980
rs80207279
52 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs756740141
CA3012981
53 N>D No ClinGen
ExAC
TOPMed
gnomAD
rs1442018532
CA357674952
56 D>N No ClinGen
gnomAD
TCGA novel 57 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs745419051
CA3012983
61 E>G No ClinGen
ExAC
gnomAD
CA3012984
rs755375373
62 K>T No ClinGen
ExAC
gnomAD
CA357675000
rs1198281033
63 T>A No ClinGen
gnomAD
CA357675004
rs1318754577
63 T>I No ClinGen
gnomAD
TCGA novel 63 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
VAR_028037
CA101672700
rs11723410
66 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
UniProt
Ensembl
NCI-TCGA
dbSNP
rs1178905666
CA357677963
67 S>G No ClinGen
TOPMed
CA357677965
rs1441976519
67 S>N No ClinGen
gnomAD
CA3013013
rs769953912
68 V>G No ClinGen
ExAC
TOPMed
gnomAD
CA3013014
rs555203609
69 P>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs555203609
CA3013015
69 P>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1457345949
CA357677993
72 P>T No ClinGen
TOPMed
gnomAD
CA357678025
rs1480602421
76 R>K No ClinGen
TOPMed
CA3013016
rs768615672
77 K>R No ClinGen
ExAC
gnomAD
CA357678040
rs1174396873
78 A>E No ClinGen
TOPMed
gnomAD
CA3013017
rs371482856
79 S>N No ClinGen
ESP
ExAC
gnomAD
rs1213643466
CA357678054
80 I>T No ClinGen
TOPMed
CA357678051
rs1560518674
80 I>V No ClinGen
Ensembl
rs1161532307
CA357678058
81 S>P No ClinGen
gnomAD
rs761682389
CA3013019
82 Y>C No ClinGen
ExAC
gnomAD
rs767064469
CA3013020
84 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1372310395
CA357678115
89 I>V No ClinGen
gnomAD
rs760074639
CA3013022
90 Q>L No ClinGen
ExAC
gnomAD
CA357678151
rs1379345974
91 Y>C No ClinGen
TOPMed
CA357678166
rs1304602673
92 I>V No ClinGen
TOPMed
rs753428627
CA3013024
93 D>V No ClinGen
ExAC
gnomAD
CA3013023
rs765937459
93 D>Y No ClinGen
ExAC
gnomAD
CA3013025
rs758908976
98 S>G No ClinGen
ExAC
CA101672777
rs972871049
98 S>I No ClinGen
TOPMed
CA101672785
rs201116246
98 S>R No ClinGen
TOPMed
rs778437451
CA3013026
100 D>G No ClinGen
ExAC
gnomAD
CA3013027
rs376715102
101 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3013030
rs200948051
102 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs200948051
CA3013029
RCV000412974
102 V>I No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA101672833
rs962336168
104 P>R No ClinGen
Ensembl
CA3013031
rs368809274
105 N>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA101672843
rs368809274
105 N>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel
CA357678502
rs1579059266
106 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
Ensembl
CA3013034
rs768527455
107 S>F No ClinGen
ExAC
gnomAD
CA3013033
rs749379015
107 S>P No ClinGen
ExAC
gnomAD
rs199979749
CA3013035
108 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs539162347
CA3013036
111 Q>E No ClinGen
ExAC
gnomAD
CA357678656
rs1418932359
112 E>G No ClinGen
TOPMed
rs577058645
CA101672918
113 K>E No ClinGen
1000Genomes
CA101672935
rs1055549708
114 T>A No ClinGen
Ensembl
CA101672950
rs545488452
115 F>L No ClinGen
1000Genomes
gnomAD
rs559024349
CA3013039
116 N>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA101672956
rs949667789
116 N>Y No ClinGen
Ensembl
rs766134493
CA3013040
117 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA357678817
rs1303002858
118 D>N No ClinGen
gnomAD
rs1341387511
CA357678876
120 V>L No ClinGen
gnomAD
CA101672966
rs183431978
123 V>L No ClinGen
1000Genomes
CA357680398
rs1256607861
124 S>F No ClinGen
gnomAD
rs770694110
CA3013063
126 P>S No ClinGen
ExAC
gnomAD
CA3013065
rs759081519
131 E>D No ClinGen
ExAC
gnomAD
CA3013066
rs764886010
132 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs780000495
CA101679811
133 Q>* No ClinGen
Ensembl
CA3013067
rs774881671
133 Q>R No ClinGen
ExAC
gnomAD
CA101679859
VAR_028038
rs2664891
135 L>F No ClinGen
UniProt
TOPMed
dbSNP
gnomAD
CA3013068
rs762344277
136 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1332914632
CA357680510
137 T>S No ClinGen
TOPMed
CA357680527
rs1165247469
138 M>I No ClinGen
gnomAD
RCV000905985
rs149019191
CA3013069
138 M>V No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs750745764
CA3013070
139 A>P No ClinGen
ExAC
gnomAD
rs2632398
VAR_028039
CA101679883
140 R>C No ClinGen
UniProt
TOPMed
dbSNP
gnomAD
rs774748875
CA3013071
140 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs766583041
CA3013072
141 R>S No ClinGen
ExAC
gnomAD
CA357680574
rs1560525396
142 N>S No ClinGen
Ensembl
CA357680580
rs754100136
143 D>N No ClinGen
ExAC
gnomAD
CA3013073
rs754100136
143 D>Y No ClinGen
ExAC
gnomAD
rs969607185
CA101679904
144 D>G No ClinGen
TOPMed
gnomAD
rs1286975257
CA357680595
144 D>N No ClinGen
TOPMed
CA101679911
rs369651132
145 I>T No ClinGen
ESP
TOPMed
CA101679939
rs925409123
151 L>V No ClinGen
TOPMed
rs1313402430
CA357680738
152 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1392006165
CA357680745
153 E>Q No ClinGen
gnomAD
CA357680817
rs1288502454
156 D>E No ClinGen
TOPMed
gnomAD
rs1315332861
CA357680822
157 L>V No ClinGen
gnomAD
rs746791930
CA3013079
173 S>T No ClinGen
ExAC
gnomAD
TCGA novel 174 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA101680017
rs985794988
175 N>S No ClinGen
gnomAD
CA3013100
rs757279940
184 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1294382540
CA357681590
185 S>N No ClinGen
TOPMed
gnomAD
CA3013102
rs745664747
187 M>T No ClinGen
ExAC
gnomAD
CA3013104
rs375345716
191 I>V No ClinGen
ESP
ExAC
gnomAD
rs535745788
CA101682123
193 A>V No ClinGen
Ensembl
rs1014891672
CA101682136
197 M>I No ClinGen
TOPMed
CA357681746
rs1372565102
197 M>K No ClinGen
TOPMed
rs1203548067
CA357681763
199 G>A No ClinGen
gnomAD
rs1246981583
CA357681777
201 A>G No ClinGen
gnomAD
rs980211165
CA101685350
203 G>V No ClinGen
TOPMed
gnomAD
rs1402579741
CA357682953
204 G>R No ClinGen
gnomAD
rs777188583
CA3013131
210 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs1314126116
CA357683034
212 S>Y No ClinGen
TOPMed
CA357683044
rs1187791123
214 S>P No ClinGen
TOPMed
gnomAD
CA357683067
rs1420750749
217 Y>C No ClinGen
TOPMed
CA357683084
rs1365846803
219 E>A No ClinGen
TOPMed
CA357683091
rs1384790579
220 D>G No ClinGen
gnomAD
CA3013134
rs775942312
224 D>E No ClinGen
ExAC
gnomAD
rs1157576770
CA357683120
224 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1418958792
CA357683124
224 D>V No ClinGen
TOPMed
CA3013135
rs763042686
226 Q>E No ClinGen
ExAC
TOPMed
gnomAD
rs1206394928
CA357683152
228 I>M No ClinGen
gnomAD
CA3013136
rs764379408
228 I>V No ClinGen
ExAC
gnomAD
rs751635002
CA3013137
229 K>Q No ClinGen
ExAC
gnomAD
TCGA novel 230 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA101685410
rs779551692
234 D>N No ClinGen
Ensembl
TCGA novel 236 G>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs753559198
CA3013162
236 G>A No ClinGen
ExAC
gnomAD
CA357684181
rs1230553212
237 E>A No ClinGen
TOPMed
CA357684185
rs1304450461
237 E>D No ClinGen
TOPMed
gnomAD
rs1300941072
CA357684186
238 E>K No ClinGen
TOPMed
CA3013165
rs370832123
240 N>S No ClinGen
ESP
ExAC
TOPMed
CA357684207
rs1306311010
241 E>K No ClinGen
TOPMed
CA357684216
rs1309771341
242 S>P No ClinGen
gnomAD
rs756518960
CA3013169
244 E>A No ClinGen
ExAC
gnomAD
VAR_028040
CA101693453
rs3103117
245 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
UniProt
Ensembl
NCI-TCGA
dbSNP
rs11722476
VAR_028041
CA3013171
247 S>N No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs768544433
CA3013173
249 W>R No ClinGen
ExAC
gnomAD
rs772457471
CA3013175
250 E>G No ClinGen
ExAC
gnomAD
rs748335254
CA3013174
250 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs773101703
CA3013176
253 E>K No ClinGen
ExAC
gnomAD
rs1159550698
CA357684312
255 I>M No ClinGen
TOPMed
CA3013177
rs760824775
255 I>V No ClinGen
ExAC
gnomAD
CA3013178
rs766219199
256 V>I No ClinGen
ExAC
gnomAD
CA357684349
rs1288887455
261 K>T No ClinGen
gnomAD
CA357684358
rs1412232017
262 E>A No ClinGen
gnomAD
TCGA novel 264 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1364704622
CA357684376
265 N>D No ClinGen
gnomAD
rs1409625376
CA357684397
267 D>V No ClinGen
TOPMed
rs759300612
CA3013180
268 K>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 270 E>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357684456
rs1238382283
274 V>E No ClinGen
TOPMed
CA3013196
rs776591806
274 V>I No ClinGen
ExAC
gnomAD
CA101694619
rs776591806
274 V>L No ClinGen
ExAC
gnomAD
TCGA novel 275 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1378755495
CA357684469
276 K>R No ClinGen
gnomAD
CA357684507
rs1322361069
281 M>V No ClinGen
TOPMed
CA3013198
rs769726151
283 T>A No ClinGen
ExAC
gnomAD
CA357684523
rs769726151
283 T>P No ClinGen
ExAC
gnomAD
rs1315239841
CA357684529
284 E>Q No ClinGen
gnomAD
CA357684536
rs1315134384
285 A>T No ClinGen
TOPMed
rs1344902818
CA357684543
286 L>V No ClinGen
gnomAD
CA3013199
rs775205670
287 E>Q No ClinGen
ExAC
gnomAD
TCGA novel 288 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 288 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs763651190
CA3013201
290 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1205341970
CA357684575
291 V>L No ClinGen
gnomAD
CA357684591
rs1403168907
293 A>E No ClinGen
TOPMed
gnomAD
rs761206799
CA3013203
296 Q>R No ClinGen
ExAC
gnomAD
rs372341021
CA3013215
298 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs781265836
CA3013216
299 Q>K No ClinGen
ExAC
gnomAD
CA357685089
rs1234267839
300 Y>C No ClinGen
gnomAD
VAR_028042
rs7439869
CA3013217
301 V>A No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs996883018
CA101696278
301 V>I No ClinGen
TOPMed
gnomAD
rs769704087
CA3013218
303 Q>P No ClinGen
ExAC
TOPMed
gnomAD
CA3013219
rs775475567
304 S>R No ClinGen
ExAC
gnomAD
CA357685149
rs1174954147
305 E>A No ClinGen
TOPMed
gnomAD
CA357685166
rs1410940101
307 P>A No ClinGen
gnomAD
CA3013220
rs369454887
307 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3013221
rs768546456
310 K>N No ClinGen
ExAC
gnomAD
rs1409398231
CA357685187
310 K>R No ClinGen
gnomAD
CA3013222
rs774037475
311 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1344142698
CA357685208
313 S>F No ClinGen
TOPMed
gnomAD
rs559885724
CA3013224
315 R>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs772793881
CA357685219
CA3013225
315 R>S No ClinGen
ExAC
gnomAD
CA357685238
rs1339662620
318 N>D No ClinGen
gnomAD
CA3013226
rs760321641
318 N>S No ClinGen
ExAC
gnomAD
CA3013227
rs765805221
320 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs1490716081
CA357685251
320 P>S No ClinGen
gnomAD
rs1579209858
CA357685272
323 A>T No ClinGen
Ensembl
rs150825146
CA3013228
324 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs772417263
CA101696405
329 K>E No ClinGen
TOPMed
TCGA novel 332 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1417757786
CA357685337
332 F>S No ClinGen
gnomAD
TCGA novel 334 M>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs201412452
CA3013232
334 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 336 A>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357685381
rs1579210047
338 N>S No ClinGen
Ensembl
CA357685385
rs1367680988
339 G>S No ClinGen
gnomAD
CA3013234
rs745941235
340 F>L No ClinGen
ExAC
gnomAD
CA101696424
rs756229280
341 N>K No ClinGen
ExAC
gnomAD
rs779946891
CA3013236
343 K>N No ClinGen
ExAC
gnomAD
COSM198791
rs749176913
CA3013237
344 R>C large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA3013239
rs200181471
344 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3013238
rs200181471
344 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA357685445
rs1315375597
347 N>H No ClinGen
gnomAD
rs754697669 347 N>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs902106176
CA101696456
347 N>S No ClinGen
Ensembl
CA101696465
rs902106176
347 N>T No ClinGen
Ensembl
rs747912885
CA3013241
348 V>I No ClinGen
ExAC
gnomAD
CA357685482
COSM1431836
rs1446006737
349 F>S large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA101696474
rs35558307
350 N>K No ClinGen
Ensembl
VAR_028043
CA101696488
rs17854344
351 P>Q No ClinGen
UniProt
Ensembl
dbSNP
RCV000950398
rs139839410
CA3013242
351 P>S No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs145303992
CA3013243
352 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA357685536
rs1449315943
353 R>K No ClinGen
TOPMed
gnomAD
rs1449315943
CA357685537
353 R>T No ClinGen
TOPMed
gnomAD
CA3013244
rs760237788
355 V>A No ClinGen
ExAC
CA357685588
rs1184580576
357 D>G No ClinGen
gnomAD
CA3013245
rs373573803
358 S>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1442960844
CA357685632
360 Y>C No ClinGen
TOPMed
gnomAD
CA357685653
rs1162757852
361 D>E No ClinGen
gnomAD
rs776307895
CA3013246
362 S>L No ClinGen
ExAC
gnomAD
rs764521045
CA3013248
363 G>R No ClinGen
ExAC
gnomAD
CA357685673
rs1175878914
363 G>V No ClinGen
TOPMed
rs1386342255
CA357685687
365 D>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA357685716
rs1434112799
366 V>D No ClinGen
gnomAD
CA3013250
rs757627876
367 G>S No ClinGen
ExAC
gnomAD
CA3013251
rs767696967
368 S>I No ClinGen
ExAC
gnomAD
CA357685764
rs1244303218
370 L>R No ClinGen
TOPMed
CA3013252
rs750694296
370 L>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs756352035
CA357685798
372 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA357685814
rs1266847736
373 D>V No ClinGen
gnomAD
TCGA novel 374 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1464786798
CA357685828
374 Y>C No ClinGen
gnomAD
TCGA novel 375 S>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1560541334
CA357685858
376 S>G No ClinGen
Ensembl
rs1245295463
CA357685887
377 G>A No ClinGen
gnomAD
CA101696591
rs886187757
381 M>V No ClinGen
Ensembl
CA357685997
rs1318929835
384 G>D No ClinGen
TOPMed
CA357685990
rs1471232317
384 G>S No ClinGen
gnomAD
CA357686166
rs1337172808
395 D>N No ClinGen
gnomAD
CA357686179
rs1408089946
396 A>G No ClinGen
gnomAD
rs199743897
CA357686187
398 I>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs199743897
CA3013259
COSM3661271
398 I>V liver [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
CA357686193
rs1317084270
399 G>S No ClinGen
TOPMed
rs773160467
CA3013260
402 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs746616116
CA3013261
403 L>S No ClinGen
ExAC
rs558752166
CA101696636
405 P>S No ClinGen
TOPMed
TCGA novel 406 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1265507784
CA357686288
413 Q>K No ClinGen
gnomAD
rs769200659
CA3013265
417 E>Q No ClinGen
ExAC
gnomAD
TCGA novel 418 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1179157918
CA357686400
421 F>L No ClinGen
gnomAD
CA357686410
rs1251529353
421 F>S No ClinGen
gnomAD
CA101696680
rs932765231
422 N>S No ClinGen
TOPMed
rs1157613743
CA357686440
423 S>N No ClinGen
TOPMed
TCGA novel 428 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs35489656
CA3013302
429 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1430692509
CA357688536
431 M>I No ClinGen
TOPMed
rs376099012
CA101706536
435 N>S No ClinGen
ESP
TOPMed
TCGA novel 436 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3013303
rs745463984
436 G>S No ClinGen
ExAC
gnomAD
CA3013304
rs769519516
442 I>L No ClinGen
ExAC
gnomAD
rs1560551856
CA357688611
442 I>R No ClinGen
Ensembl
CA101706543
rs929971004
443 W>* No ClinGen
Ensembl
CA357688616
rs1335850962
443 W>L No ClinGen
gnomAD
CA101706541
rs200569328
443 W>R No ClinGen
TOPMed
CA3013305
rs779364837
449 I>L No ClinGen
ExAC
gnomAD
rs1208150704
CA357688660
449 I>M No ClinGen
TOPMed
TCGA novel 452 R>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 453 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748810392
CA3013306
454 V>I No ClinGen
ExAC
gnomAD
TCGA novel 455 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773779610
CA3013308
456 I>M No ClinGen
ExAC
gnomAD
rs1206623450
CA357688747
461 K>N No ClinGen
gnomAD
CA357688782
rs1461587526
466 S>L No ClinGen
gnomAD
CA3013313
rs765506477
475 M>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs775415504
CA3013314
476 L>I No ClinGen
ExAC
gnomAD
rs1339864110
CA357688863
478 G>A No ClinGen
TOPMed
rs201401547
CA101706604
478 G>R No ClinGen
Ensembl
CA3013315
rs369172332
479 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA357688882
rs1159041455
481 G>D No ClinGen
gnomAD
CA3013317
rs751594432
482 G>R No ClinGen
ExAC
gnomAD
CA357688908
rs1321218870
485 I>V No ClinGen
gnomAD
rs750236630
CA3013320
488 P>L No ClinGen
ExAC
gnomAD
CA3013321
rs755665740
489 S>C No ClinGen
ExAC
gnomAD
rs755665740
CA357688939
489 S>F No ClinGen
ExAC
gnomAD
rs779817379
CA3013322
490 I>L No ClinGen
ExAC
gnomAD
rs2306802
CA357688965
493 Q>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1205474418
CA357675359
503 V>I No ClinGen
gnomAD
rs1205474418
CA357675361
503 V>L No ClinGen
gnomAD
rs1156927855
CA357675392
505 L>F No ClinGen
TOPMed
rs781754808
CA3013346
510 L>F No ClinGen
ExAC
gnomAD
rs1379401348
CA357675557
514 H>R No ClinGen
TOPMed
gnomAD
rs1270238144
CA357675548
514 H>Y No ClinGen
gnomAD
CA3013349
COSM217328
rs780585922
519 I>V liver [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA357675878
rs1579311919
527 G>E No ClinGen
Ensembl
CA357675902
rs1579311971
531 Q>K No ClinGen
Ensembl
CA357675917
rs1435546652
533 I>V No ClinGen
gnomAD
CA101660161
rs3113842
538 Y>H No ClinGen
Ensembl
rs749684131
CA3013368
540 Y>C No ClinGen
ExAC
gnomAD
CA357675981
rs1579312114
542 E>D No ClinGen
Ensembl
rs779346888
CA3013370
542 E>K No ClinGen
ExAC
gnomAD
rs748148546
CA101660197
544 N>I No ClinGen
ExAC
TOPMed
gnomAD
rs748148546
CA3013371
544 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1330347102
CA357675996
545 N>D No ClinGen
gnomAD
CA101660207
rs61741933
551 V>G No ClinGen
Ensembl
CA101660206
rs925841496
551 V>I No ClinGen
TOPMed
gnomAD
rs760625348
CA3013374
557 I>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1579312264
CA357676072
557 I>V No ClinGen
Ensembl
TCGA novel 562 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3013387
rs370363007
565 N>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs772013442
CA101661118
566 L>V No ClinGen
Ensembl
CA3013389
rs543532635
570 T>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs201690975
CA3013390
570 T>S No ClinGen
ExAC
TOPMed
gnomAD
rs1436820872
CA357676185
571 L>S No ClinGen
TOPMed
rs1409646546
CA357676195
COSM588867
572 K>N lung [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1347832446
CA357676206
574 L>H No ClinGen
TOPMed
CA357676203
rs1201362993
574 L>V No ClinGen
TOPMed
rs148851766
CA3013391
575 C>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 576 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs972221942
CA101661124
577 Y>C No ClinGen
TOPMed
CA101661278
rs770801956
583 R>H No ClinGen
Ensembl
rs3103135
CA101661285
589 N>H No ClinGen
Ensembl
rs1199339194
CA357676325
589 N>S No ClinGen
gnomAD
rs1379204368
CA357676340
591 H>R No ClinGen
gnomAD
rs753012478
CA3013412
593 R>K No ClinGen
ExAC
TOPMed
gnomAD
rs1370724829
CA357676386
597 Y>C No ClinGen
gnomAD
CA3013414
rs777920671
598 N>S No ClinGen
ExAC
gnomAD
CA357676445
rs1386012911
604 Y>C No ClinGen
TOPMed
CA357676469
rs1440635478
607 A>V No ClinGen
gnomAD
CA3013433
rs763264827
608 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA3013435
rs751729733
610 S>G No ClinGen
ExAC
gnomAD
CA3013436
rs757499753
611 S>C No ClinGen
ExAC
gnomAD
rs1247073980
CA357676502
612 D>E No ClinGen
gnomAD
CA357676504
rs1267145843
613 D>N No ClinGen
gnomAD
CA357676514
rs1189321599
614 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA357676513
rs1189321599
614 R>G No ClinGen
TOPMed
gnomAD
rs750514840
CA3013438
614 R>H No ClinGen
ExAC
TOPMed
CA357676524
rs1197654465
615 S>R No ClinGen
TOPMed
rs1432986576
CA357676550
620 L>Q No ClinGen
TOPMed
CA3013442
rs768385881
625 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs768385881
CA101662643
625 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 627 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357676628
rs1166204678
631 H>R No ClinGen
gnomAD
TCGA novel 634 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772794075
CA3013446
635 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1391340863
CA357676670
637 G>S No ClinGen
gnomAD
rs1053673489
CA101662686
638 S>C No ClinGen
Ensembl
rs1433348876
CA357676683
639 I>V No ClinGen
gnomAD
rs151125076
CA3013448
643 H>Y No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs775908103
CA3013449
645 M>T No ClinGen
ExAC
gnomAD
rs773473258
CA3013475
649 A>V No ClinGen
ExAC
CA3013476
rs760981274
652 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA101663342
rs866232826
652 R>S No ClinGen
Ensembl
rs766331484
CA3013477
658 T>I No ClinGen
ExAC
gnomAD
rs1174290720
CA357676824
659 P>T No ClinGen
gnomAD
rs753959232
CA3013478
660 V>I No ClinGen
ExAC
gnomAD
rs1358805678
CA357676958
678 M>V No ClinGen
TOPMed
rs1439996220
CA357676975
680 S>G No ClinGen
gnomAD
CA3013482
rs528568208
681 S>G No ClinGen
1000Genomes
ExAC
gnomAD
rs752956662
CA101663395
681 S>N No ClinGen
Ensembl
CA357676986
rs1368124180
681 S>R No ClinGen
gnomAD
CA3013483
rs758314184
682 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs1421308896
CA357677021
686 I>T No ClinGen
TOPMed
TCGA novel 687 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357677028
rs1378204418
687 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1300826479
CA357677037
689 M>V No ClinGen
gnomAD
TCGA novel 692 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357677106
rs1475126679
697 A>T No ClinGen
gnomAD
TCGA novel 697 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA101664256
rs931874180
698 D>N No ClinGen
TOPMed
TCGA novel 699 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1414469031
CA357677123
699 E>V No ClinGen
gnomAD
CA357677145
rs1371008351
702 I>K No ClinGen
gnomAD
rs1169112891
CA357677143
702 I>V No ClinGen
TOPMed
gnomAD
CA357677151
rs1467225165
703 Y>H No ClinGen
gnomAD
CA3013507
rs575801541
706 E>D No ClinGen
1000Genomes
ExAC
gnomAD
CA357677174
rs1407056951
706 E>Q No ClinGen
gnomAD
TCGA novel 718 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357677281
rs1358344630
721 R>K No ClinGen
TOPMed
rs1324262980
CA357677293
723 V>I No ClinGen
gnomAD
CA3013520
rs375467421
729 K>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
RCV000888974
rs138860144
CA3013523
733 P>A No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA357677379
rs1230643946
733 P>L No ClinGen
TOPMed
gnomAD
COSM258060
rs761708730
CA3013524
737 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA101664435
rs868015422
738 I>T No ClinGen
Ensembl
TCGA novel 739 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3013527
rs755795846
745 E>K No ClinGen
ExAC
gnomAD
rs1256746627
CA357677484
748 E>A No ClinGen
gnomAD
rs1483319497
CA357677487
748 E>D No ClinGen
gnomAD
rs1256746627
CA357677486
748 E>V No ClinGen
gnomAD
rs753363574
CA3013529
749 Q>H No ClinGen
ExAC
gnomAD
CA3013531
rs758897655
753 G>C No ClinGen
ExAC
gnomAD
CA3013530
rs758897655
753 G>S No ClinGen
ExAC
gnomAD
RCV001253615
CA357677529
rs1306010332
755 F>L No ClinGen
ClinVar
dbSNP
gnomAD
rs1001956167
CA101664524
756 N>D No ClinGen
Ensembl
CA3013532
rs142593051
756 N>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1426748985
CA357677567
760 K>R No ClinGen
gnomAD
CA357677582
rs1311689894
762 I>M No ClinGen
gnomAD
CA3013533
rs371198232
762 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1371744926
CA357677586
763 N>S No ClinGen
TOPMed
gnomAD
rs1369650190
CA357677596
764 N>I No ClinGen
TOPMed
TCGA novel 765 L>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750056186 768 N>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 768 N>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1369196933
CA357677662
769 T>I No ClinGen
TOPMed
gnomAD
CA357677669
rs1258974023
770 E>D No ClinGen
gnomAD
CA357677667
rs1298590403
770 E>G No ClinGen
gnomAD
CA357677677
rs1344491826
771 M>I No ClinGen
gnomAD
CA357677684
rs754527654
772 C>F No ClinGen
ExAC
gnomAD
CA3013549
rs754527654
772 C>Y No ClinGen
ExAC
gnomAD
rs1579338099
CA357677691
773 N>S No ClinGen
Ensembl
CA101664732
rs112326108
774 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs778305458
CA3013550
774 V>I No ClinGen
ExAC
gnomAD
CA101664740
rs752062564
777 Q>H No ClinGen
ExAC
gnomAD
rs1274851786
CA357677729
778 L>F No ClinGen
gnomAD
rs1436098748
CA357677779
785 P>S No ClinGen
TOPMed
CA3013552
rs757705893
788 H>Y No ClinGen
ExAC
gnomAD
CA3013553
rs781559336
789 R>S No ClinGen
ExAC
gnomAD
CA101664754
rs975789003
790 Q>R No ClinGen
TOPMed
gnomAD
rs780463117
CA3013556
794 A>S No ClinGen
ExAC
gnomAD
CA357677842
rs1484136152
794 A>V No ClinGen
TOPMed
rs1373042201
CA357677882
800 M>V No ClinGen
gnomAD
rs749356198
CA357677905
803 L>F No ClinGen
ExAC
gnomAD
rs749356198
CA3013557
803 L>V No ClinGen
ExAC
gnomAD
TCGA novel 808 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1027092029
CA101666142
808 P>T No ClinGen
TOPMed
CA357678318
rs1416243942
810 H>Y No ClinGen
gnomAD
CA357678342
rs767950479
811 C>F No ClinGen
ExAC
TOPMed
gnomAD
rs767950479
CA3013574
811 C>Y No ClinGen
ExAC
TOPMed
gnomAD
CA357678396
rs1190780708
814 N>D No ClinGen
TOPMed
rs138326521
CA101666175
815 P>A No ClinGen
ESP
ExAC
gnomAD
CA3013576
rs138326521
815 P>S No ClinGen
ESP
ExAC
gnomAD
rs563304673
CA3013577
816 D>E No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA357678490
rs1237354316
819 F>L No ClinGen
TOPMed
CA101666217
rs895123297
820 E>D No ClinGen
Ensembl
CA357678494
rs1403069906
820 E>Q No ClinGen
gnomAD
CA101666241
rs1025413412
822 M>I No ClinGen
Ensembl
CA3013578
rs377604717
CA357678585
823 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA101666255
rs79308346
825 M>L No ClinGen
Ensembl
rs778999358
CA3013580
832 V>I No ClinGen
ExAC
gnomAD
rs1317452692
CA357678809
835 K>R No ClinGen
TOPMed
gnomAD
CA3013583
rs200626666
838 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3013585
rs373034529
841 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs958239996
CA101666319
843 F>L No ClinGen
gnomAD
CA3013586
CA3013587
rs776444789
844 Q>H No ClinGen
ExAC
TOPMed
gnomAD
CA357678981
rs989618306
CA101666357
847 M>I No ClinGen
TOPMed
rs147230441
CA3013588
847 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs775036233
CA3013589
848 D>E No ClinGen
ExAC
gnomAD
rs377400815
CA3013590
857 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3013591
rs768125147
860 G>A No ClinGen
ExAC
CA357679073
rs1158666263
861 C>Y No ClinGen
gnomAD
rs756693746
CA3013593
867 K>R No ClinGen
ExAC
gnomAD
TCGA novel 868 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs921733032
CA101666381
868 Q>R No ClinGen
TOPMed
TCGA novel 869 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA101667212
rs1046452240
873 V>I No ClinGen
Ensembl
TCGA novel 880 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs754196866
CA3013612
885 I>V No ClinGen
ExAC
gnomAD
rs1281085965
CA357679260
886 L>V No ClinGen
gnomAD
rs267600302
COSM13923
CA101667285
888 V>D skin [Cosmic] No ClinGen
cosmic curated
Ensembl
rs199718824
CA3013614
892 H>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1450182385
CA357679312
893 H>L No ClinGen
gnomAD
rs752800094
CA3013615
893 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3013616
rs138356072
894 Q>H No ClinGen
1000Genomes
ExAC
gnomAD
CA357679331
rs1412449811
896 R>K No ClinGen
TOPMed
CA357679361
rs1560568330
900 L>* No ClinGen
Ensembl
CA3013645
rs763142008
913 I>N No ClinGen
ExAC
gnomAD
rs1206007756
CA357679476
915 E>K No ClinGen
TOPMed
CA3013647
rs751635784
918 T>A No ClinGen
ExAC
gnomAD
rs771184889
CA3013649
919 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA357679513
rs1185689986
920 M>V No ClinGen
gnomAD
rs756107825
CA3013651
921 D>G No ClinGen
ExAC
TOPMed
gnomAD
CA101669086
rs968875276
921 D>Y No ClinGen
Ensembl
rs778772656
CA3013655
933 G>R No ClinGen
ExAC
gnomAD
CA357679814
rs1312790254
945 I>M No ClinGen
gnomAD
CA3013658
rs772778426
948 D>H No ClinGen
ExAC
gnomAD
TCGA novel 948 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 949 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357679941
rs1278015436
954 Y>C No ClinGen
gnomAD
TCGA novel 963 C>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs150777961
CA3013661
969 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs17857297
VAR_028044
CA101671131
972 V>A No ClinGen
UniProt
Ensembl
dbSNP
CA3013676
rs747733445
975 I>T No ClinGen
ExAC
gnomAD
CA3013680
rs139130080
981 G>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3013679
CA357680594
rs191254950
981 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3013682
rs749812122
983 I>T No ClinGen
ExAC
gnomAD
rs768942719
CA3013683
986 S>T No ClinGen
ExAC
gnomAD
TCGA novel 990 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 991 N>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA357680765
rs1254413939
995 L>F No ClinGen
gnomAD
rs1273335234
CA357680775
996 K>R No ClinGen
gnomAD
TCGA novel 998 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 1001 M>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1247529092
CA357680858
1003 T>A No ClinGen
TOPMed
CA357680865
rs1374173184
1003 T>I No ClinGen
gnomAD
CA357681217
rs1282802642
1008 D>V No ClinGen
TOPMed
CA357681244
rs1223506986
1010 G>E No ClinGen
TOPMed
rs1457637247
CA357681286
1012 M>I No ClinGen
gnomAD
rs1289651944
CA357681293
1013 P>A No ClinGen
gnomAD
rs1387316964
CA357681299
1013 P>L No ClinGen
gnomAD
rs1317692420
CA357681436
1024 M>I No ClinGen
TOPMed
rs61755304
CA3013703
1024 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs61755304
CA101675228
1024 M>V No ClinGen
ExAC
TOPMed
gnomAD

3 associated diseases with Q9H4L7

[MIM: 136000]: Adermatoglyphia (ADERM)

An autosomal dominant condition characterized by the lack of epidermal ridges on the palms and soles, which results in the absence of fingerprints, and is associated with a reduced number of sweat gland openings and reduced sweating of palms and soles. {ECO:0000269|PubMed:21820097, ECO:0000269|PubMed:24909267}. Note=The disease is caused by variants affecting the gene represented in this entry. Splice site mutations causing aberrant splicing of skin-specific isoform 3 are likely to exert a loss-of-function effect and are involved in ADERM. {ECO:0000269|PubMed:21820097, ECO:0000269|PubMed:24909267}.

[MIM: 129200]: Basan syndrome (BSNS)

An autosomal dominant form of adermatoglyphia associated with congenital facial milia, acral blistering, digital contractures, and nail abnormalities. Adermatoglyphia is defined by the lack of epidermal ridges on the palms and soles, which results in the absence of fingerprints. {ECO:0000269|PubMed:24664640, ECO:0000269|PubMed:26932190}. Note=The disease is caused by variants affecting the gene represented in this entry. Splice site mutations causing aberrant splicing of skin-specific isoform 3 are likely to exert a loss-of-function effect and are involved in BSNS. {ECO:0000269|PubMed:24664640, ECO:0000269|PubMed:26932190}.

[MIM: 181600]: Huriez syndrome (HRZ)

An autosomal dominant syndrome characterized by atrophic fibrosis of the skin of the limbs, nail hypoplasia, and palmoplantar keratoderma. Malignant degeneration of affected skin resulting in aggressive squamous cell carcinoma and early metastasis formation is a distinctive feature of the syndrome. {ECO:0000269|PubMed:29409814}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An autosomal dominant condition characterized by the lack of epidermal ridges on the palms and soles, which results in the absence of fingerprints, and is associated with a reduced number of sweat gland openings and reduced sweating of palms and soles. {ECO:0000269|PubMed:21820097, ECO:0000269|PubMed:24909267}. Note=The disease is caused by variants affecting the gene represented in this entry. Splice site mutations causing aberrant splicing of skin-specific isoform 3 are likely to exert a loss-of-function effect and are involved in ADERM. {ECO:0000269|PubMed:21820097, ECO:0000269|PubMed:24909267}.
  • An autosomal dominant form of adermatoglyphia associated with congenital facial milia, acral blistering, digital contractures, and nail abnormalities. Adermatoglyphia is defined by the lack of epidermal ridges on the palms and soles, which results in the absence of fingerprints. {ECO:0000269|PubMed:24664640, ECO:0000269|PubMed:26932190}. Note=The disease is caused by variants affecting the gene represented in this entry. Splice site mutations causing aberrant splicing of skin-specific isoform 3 are likely to exert a loss-of-function effect and are involved in BSNS. {ECO:0000269|PubMed:24664640, ECO:0000269|PubMed:26932190}.
  • An autosomal dominant syndrome characterized by atrophic fibrosis of the skin of the limbs, nail hypoplasia, and palmoplantar keratoderma. Malignant degeneration of affected skin resulting in aggressive squamous cell carcinoma and early metastasis formation is a distinctive feature of the syndrome. {ECO:0000269|PubMed:29409814}. Note=The disease is caused by variants affecting the gene represented in this entry.

5 regional properties for Q9H4L7

Type Name Position InterPro Accession
domain SNF2, N-terminal 513 - 785 IPR000330
domain Helicase, C-terminal 857 - 1010 IPR001650
domain Ubiquitin system component CUE 157 - 199 IPR003892-1
domain Ubiquitin system component CUE 251 - 294 IPR003892-2
domain Helicase superfamily 1/2, ATP-binding domain 493 - 687 IPR014001

Functions

Description
EC Number 3.6.4.12 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Nucleus
  • Chromosome
  • Colocalizes with PCNA at replication forks during S phase
  • Recruited to double-strand breaks (DSBs) sites of DNA damage
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
heterochromatin A compact and highly condensed form of chromatin that is refractory to transcription.
nuclear replication fork The Y-shaped region of a nuclear replicating DNA molecule, resulting from the separation of the DNA strands and in which the synthesis of new strands takes place. Also includes associated protein complexes.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
site of double-strand break A region of a chromosome at which a DNA double-strand break has occurred. DNA damage signaling and repair proteins accumulate at the lesion to respond to the damage and repair the DNA to form a continuous DNA helix.

8 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
ATP-dependent activity, acting on DNA Catalytic activity that acts to modify DNA, driven by ATP hydrolysis.
ATP-dependent chromatin remodeler activity An activity, driven by ATP hydrolysis, that modulates the contacts between histones and DNA, resulting in a change in chromosome architecture within the nucleosomal array, leading to chromatin remodeling.
chromatin binding Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
DNA helicase activity Unwinding of a DNA helix, driven by ATP hydrolysis.
ubiquitin binding Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation.

6 GO annotations of biological process

Name Definition
chromatin remodeling A dynamic process of chromatin reorganization resulting in changes to chromatin structure. These changes allow DNA metabolic processes such as transcriptional regulation, DNA recombination, DNA repair, and DNA replication.
chromosome separation The cell cycle process in which paired chromosomes are detached from each other. Chromosome separation begins with the release of cohesin complexes from chromosomes; in budding yeast, this includes the cleavage of cohesin complexes along the chromosome arms, followed by the separation of the centromeric regions. Chromosome separation also includes formation of chromatid axes mediated by condensins, and ends with the disentangling of inter-sister catenation catalyzed by topoisomerase II (topo II).
DNA double-strand break processing The 5' to 3' exonucleolytic resection of the DNA at the site of the break to form a 3' single-strand DNA overhang.
histone H3 deacetylation The modification of histone H3 by the removal of one or more acetyl groups.
histone H4 deacetylation The modification of histone H4 by the removal of one or more acetyl groups.
regulation of DNA recombination Any process that modulates the frequency, rate or extent of DNA recombination, a DNA metabolic process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P31380 FUN30 ATP-dependent helicase FUN30 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q9VL72 Etl1 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 homolog Drosophila melanogaster (Fruit fly) PR
P28370 SMARCA1 Probable global transcription activator SNF2L1 Homo sapiens (Human) SS
O60264 SMARCA5 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 Homo sapiens (Human) EV
10 20 30 40 50 60
MNLFNLDRFR FEKRNKIEEA PEATPQPSQP GPSSPISLSA EEENAEGEVS RANTPDSDIT
70 80 90 100 110 120
EKTEDSSVPE TPDNERKASI SYFKNQRGIQ YIDLSSDSED VVSPNCSNTV QEKTFNKDTV
130 140 150 160 170 180
IIVSEPSEDE ESQGLPTMAR RNDDISELED LSELEDLKDA KLQTLKELFP QRSDNDLLKL
190 200 210 220 230 240
IESTSTMDGA IAAALLMFGD AGGGPRKRKL SSSSEPYEED EFNDDQSIKK TRLDHGEESN
250 260 270 280 290 300
ESAESSSNWE KQESIVLKLQ KEFPNFDKQE LREVLKEHEW MYTEALESLK VFAEDQDMQY
310 320 330 340 350 360
VSQSEVPNGK EVSSRSQNYP KNATKTKLKQ KFSMKAQNGF NKKRKKNVFN PKRVVEDSEY
370 380 390 400 410 420
DSGSDVGSSL DEDYSSGEEV MEDGYKGKIL HFLQDASIGE LTLIPQCSQK KAQKITELRP
430 440 450 460 470 480
FNSWEALFTK MSKTNGLSED LIWHCKTLIQ ERDVVIRLMN KCEDISNKLT KQVTMLTGNG
490 500 510 520 530 540
GGWNIEQPSI LNQSLSLKPY QKVGLNWLAL VHKHGLNGIL ADEMGLGKTI QAIAFLAYLY
550 560 570 580 590 600
QEGNNGPHLI VVPASTIDNW LREVNLWCPT LKVLCYYGSQ EERKQIRFNI HSRYEDYNVI
610 620 630 640 650 660
VTTYNCAISS SDDRSLFRRL KLNYAIFDEG HMLKNMGSIR YQHLMTINAN NRLLLTGTPV
670 680 690 700 710 720
QNNLLELMSL LNFVMPHMFS SSTSEIRRMF SSKTKSADEQ SIYEKERIAH AKQIIKPFIL
730 740 750 760 770 780
RRVKEEVLKQ LPPKKDRIEL CAMSEKQEQL YLGLFNRLKK SINNLEKNTE MCNVMMQLRK
790 800 810 820 830 840
MANHPLLHRQ YYTAEKLKEM SQLMLKEPTH CEANPDLIFE DMEVMTDFEL HVLCKQYRHI
850 860 870 880 890 900
NNFQLDMDLI LDSGKFRVLG CILSELKQKG DRVVLFSQFT MMLDILEVLL KHHQHRYLRL
910 920 930 940 950 960
DGKTQISERI HLIDEFNTDM DIFVFLLSTK AGGLGINLTS ANVVILHDID CNPYNDKQAE
970 980 990 1000 1010 1020
DRCHRVGQTK EVLVIKLISQ GTIEESMLKI NQQKLKLEQD MTTVDEGDEG SMPADIATLL
KTSMGL